Novartis reported $3.86B in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US USD 7.41B 84M
Amgen AMGN:US USD 2.54B 364M
AstraZeneca AZN:LN USD 2.29B 796M
Canopy Growth Corp WEED:CN CAD -267104000 43.41M
Catalent CTLT:US USD 167M 111M
Corcept Therapeutics CORT:US USD 24.28M 8.73M
Eli Lilly And LLY:US USD 2.04B 38.3M
Gilead Sciences GILD:US USD 2.52B 357M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Glaxosmithkline GSK:US GBP 1.6B 409.03M
Horizon Pharma HZNP:US USD 340.7M 25.6M
JAZZ PHA JAZZ:US USD -46767000 464.14M
Johnson & Johnson JNJ:US USD 7.42B 655M
Merk MRK:US USD 4.89B 560M
Novartis NOVN:VX USD 3.86B 195M
Pacira Pharmaceuticals PCRX:US USD 46.48M 4.25M
Perrigo Ordinary Shares PRGO:US USD 112.7M 16M
Pfizer PFE:US USD 7.38B 3.3B
Prestige Brands PBH:US USD 68.12M 1.52M
Roche Holding ROG:VX 8.85B 3.26B
Sanofi SAN:FP EUR 2.75B 1.68B
Supernus Pharmaceuticals SUPN:US USD 35.14M 35.58M
Valeant Pharmaceuticals VRX:CN USD 458M 129M
Zoetis ZTS:US USD 679M 35M